Remarkably, ACSL6 expression is typically diminished in various cancer types, yet it is notably elevated in CRC, where its overexpression is linked to increased cellular proliferation and elevated levels of glycolytic products (Parsazad et al., 2023). The gene discussed is ACSL6; the disease is colorectal carcinoma.